Cannabis

Search documents
Should You Buy or Sell CURLF Stock Amid Renewed Legalization Hopes?
ZACKS· 2025-10-08 15:20
Key Takeaways Curaleaf stock has surged amid Trump's favorable stance on marijuana rescheduling.Revenues fell 8% in Q2 2025 as U.S. sales weakened despite 62% international growth.CURLF expands via new stores and high-margin products but faces stiff competition.A leading multistate cannabis operator, Curaleaf Holdings’ (CURLF) stock has skyrocketed over 200% in the past three months, largely driven by support from the Trump administration.In the past couple of months, President Trump has spoken favorably ab ...
Genuine Marketing Group Inc. (OTC: GMGZ) and IgniteIt Inc. form industry defining partnership supporting cannabis industry stakeholders, consumers and regulators
Prnewswire· 2025-10-08 12:00
, /PRNewswire/ -- Direct from the IgniteIt Cannabis Market Spotlight: California, Genuine Marketing Group Inc. (OTC: GMGZ) is pleased to announce a strategic partnership with event organizer and industry leader, IgniteIt. The partnership serves to align IgniteIt Inc., formally known as Benzinga Cannabis, and GMGZ via cannabis investor connection, customer acquisition, marketing, and event integration to maximize visibility, revenue, and long-term growth for both organizations. Fueled by GMGZ's launch into ...
Is Now the Time to Finally Buy Pot Stocks Again?
The Motley Fool· 2025-10-08 08:30
The potential for cannabis reform has made investors bullish on the industry in recent weeks.Investing in cannabis stocks has yielded abysmal returns for investors in recent years. During the past five years, the S&P 500 has roughly doubled in value. But during that time, the value of the AdvisorShares Pure US Cannabis ETF (MSOS 1.30%) has declined by a whopping 77%. Lately, however, there's been renewed interest in cannabis. The U.S. government has been talking about potentially rescheduling the substance ...
Why Tilray Stock Leaped 8% Higher on Tuesday
Yahoo Finance· 2025-10-07 21:13
Key Points No less than three U.S. Republican senators expressed support for marijuana law reform in a set of recent interviews. President Trump is currently mulling a significant change in the legal designation of the drug. 10 stocks we like better than Tilray Brands › The slow-walk process that is potential de facto marijuana legalization in this country seemed to take a little step forward on Tuesday. This positively affected certain cannabis stocks based in both the U.S. and Canada, notably Til ...
JP Brand Advisors and Canopy USA Form Strategic Partnership to Expand Hemp Beverage Distribution
Prnewswire· 2025-10-07 12:01
Core Insights - JP Brand Advisors and Canopy USA have formed a strategic partnership to enhance the distribution of Wana Wellness's hemp-based beverages and gummies in the U.S. market [1][3] - The partnership highlights the growing focus on hemp-based functional beverages, which are gaining traction due to increasing consumer demand for wellness-oriented products [2][4] Company Overview - JP Brand Advisors acts as an outsourced sales and strategy partner for beverage alcohol and emerging functional beverage brands, providing market coverage and distributor management [5] - Canopy USA is a holding company with a significant interest in the U.S. cannabis market, owning Wana Brands, a leader in North American edibles, and other cannabis-related entities [6] Market Trends - There is a rising interest among U.S. retailers and distributors in non-alcoholic, functional, and hemp-infused beverages, driven by changing consumer preferences and clearer regulations in key markets [4]
Cannara Announces DTC Eligibility to Facilitate U.S. Investor Access and Strengthens Balance Sheet through completion of Debt-to-Equity Conversion
Globenewswire· 2025-10-07 12:00
Core Insights - Cannara Biotech Inc. has achieved DTC eligibility for its common shares, enhancing trading liquidity and access for U.S. investors [1][2][3] - The company completed the issuance of 3,462,763 common shares to Olymbec Investments Inc. to settle approximately $6.2 million in debt, which includes $4.7 million in principal and $1.5 million in accrued interest [3][4] - The DTC eligibility is expected to broaden Cannara's shareholder base and increase visibility in the U.S. market, particularly in light of potential federal regulatory reforms in the cannabis industry [3][4] Company Overview - Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis products, operating two mega facilities in Québec with a total area of over 1,650,000 sq. ft. [1][7] - The company has a potential annual cultivation output of 100,000 kg, leveraging low electricity costs in Québec to produce affordable cannabis products [7] Financial Strategy - The completion of the Olymbec share issuance is aimed at reducing debt leverage and interest obligations, thereby preserving liquidity for long-term growth strategies [4] - The transaction is anticipated to strengthen Cannara's balance sheet and enhance financial flexibility [4]
TerrAscend to Host Third Quarter 2025 Earnings Conference Call
Globenewswire· 2025-10-07 12:00
TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that it will host a scheduled conference call to discuss the results for its third quarter ended September 30, 2025 on Thursday, November 6, 2025 at 5:00 p.m. Eastern Time. The Company will report its financial results for the third quarter 2025 the same day after market close. CONFERENCE CALL DETAILS Date:Thursday, November 6, 20 ...
Tilray Brands Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Benzinga· 2025-10-07 06:51
Tilray Brands, Inc. (NASDAQ:TLRY) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 9.Analysts expect the Leamington, Canada-based company to report a quarterly loss at 2 cents per share, versus a year-ago loss of 1 cent per share. Tilray Brands projects quarterly revenue of $204.55 million, compared to $200.04 million a year earlier, according to data from Benzinga Pro.On Aug. 28, Tilray Brands' medical division expanded its portfolio in Germany with three newly ...
Tilray Brands Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Tilray Brands (NASDAQ:TLRY)
Benzinga· 2025-10-07 06:51
Tilray Brands, Inc. (NASDAQ:TLRY) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 9.Analysts expect the Leamington, Canada-based company to report a quarterly loss at 2 cents per share, versus a year-ago loss of 1 cent per share. Tilray Brands projects quarterly revenue of $204.55 million, compared to $200.04 million a year earlier, according to data from Benzinga Pro.On Aug. 28, Tilray Brands' medical division expanded its portfolio in Germany with three newly ...
From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects
ZACKS· 2025-10-06 18:16
Marijuana Exchange-Traded Funds (ETFs) have been experiencing a dramatic resurgence lately, some even soaring more than 100% over the past three months after delivering a devastating performance in 2024. This rebound, following significant gains delivered by major Cannabis stocks like Tilray Brands ((TLRY), was largely driven by the current U.S. administration’s notable push to legalize marijuana.The Journey From Loss to Lift-Off The cannabis market, despite experiencing an enormous demand trend, has been p ...